Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...

Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

The results revealed that taking both doses of Pfizer's COVID-19 vaccine led to fewer endothelial cells in the eye and ...

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, ...

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

The head of Pfizer Canada says the pharmaceutical giant is entirely focused on meeting its upcoming delivery targets and that it’s possible the company could continue to accelerate shipments of ...

Pfizer-BioNTech's COVID-19 vaccine has a new name: Comirnaty. If your brain starts to melt a little when you try to figure out how it's pronounced, don't worry. Experts say there are valid ...